Cargando…
An historical overview over Pharmacovigilance
Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the qua...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132952/ https://www.ncbi.nlm.nih.gov/pubmed/29948743 http://dx.doi.org/10.1007/s11096-018-0657-1 |
_version_ | 1783354423282499584 |
---|---|
author | Fornasier, Giulia Francescon, Sara Leone, Roberto Baldo, Paolo |
author_facet | Fornasier, Giulia Francescon, Sara Leone, Roberto Baldo, Paolo |
author_sort | Fornasier, Giulia |
collection | PubMed |
description | Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the present day, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentially letters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today’s modern and ultra-structured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve such important results for man’s health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in future years. |
format | Online Article Text |
id | pubmed-6132952 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-61329522018-09-13 An historical overview over Pharmacovigilance Fornasier, Giulia Francescon, Sara Leone, Roberto Baldo, Paolo Int J Clin Pharm Commentary Pharmacovigilance started about 170 years ago, although it was not yet named as such at that time. It is structured activity in the professional health field, with important social and commercial implications aimed at monitoring the risk/benefit ratio of drugs, improving patient’s safety and the quality of life. In this commentary we report the milestones of pharmacovigilance up to the present day, in order to understand all the steps that have characterized the historical evolution; from the first reports, which were essentially letters or warnings sent by clinicians to publishers of important and famous scientific journals, up to today’s modern and ultra-structured electronic registries. The historical phases also help us to understand why pharmacovigilance helped us to achieve such important results for man’s health and for pharmacology itself, and to identify the challenges that await Pharmacovigilance in future years. Springer International Publishing 2018-06-15 2018 /pmc/articles/PMC6132952/ /pubmed/29948743 http://dx.doi.org/10.1007/s11096-018-0657-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Commentary Fornasier, Giulia Francescon, Sara Leone, Roberto Baldo, Paolo An historical overview over Pharmacovigilance |
title | An historical overview over Pharmacovigilance |
title_full | An historical overview over Pharmacovigilance |
title_fullStr | An historical overview over Pharmacovigilance |
title_full_unstemmed | An historical overview over Pharmacovigilance |
title_short | An historical overview over Pharmacovigilance |
title_sort | historical overview over pharmacovigilance |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132952/ https://www.ncbi.nlm.nih.gov/pubmed/29948743 http://dx.doi.org/10.1007/s11096-018-0657-1 |
work_keys_str_mv | AT fornasiergiulia anhistoricaloverviewoverpharmacovigilance AT francesconsara anhistoricaloverviewoverpharmacovigilance AT leoneroberto anhistoricaloverviewoverpharmacovigilance AT baldopaolo anhistoricaloverviewoverpharmacovigilance AT fornasiergiulia historicaloverviewoverpharmacovigilance AT francesconsara historicaloverviewoverpharmacovigilance AT leoneroberto historicaloverviewoverpharmacovigilance AT baldopaolo historicaloverviewoverpharmacovigilance |